Medical News

RSS

Six papers published by PNAS in 2013 to receive Cozzarelli Prize

The Proceedings of the National Academy of Sciences (PNAS) Editorial Board has selected six papers published by PNAS in 2013 to receive the Cozzarelli Prize, an award that recognizes outstanding contributions to the scientific disciplines represented by the National Academy of Sciences.

6 Mar 2014

Study investigates possible links between sleep and omega-3 DHA fatty acid status in healthy children

A randomised placebo-controlled study by the University of Oxford suggests that higher levels of omega-3 DHA, the group of long-chain fatty acids found in algae and seafood, are associated with better sleep.

6 Mar 2014

House votes to delay individual mandate

The House took its 50th vote to change the health law, passing a bill that would delay the individual mandate to carry health insurance for one year. The measure will likely never be taken up in the Democrat-led Senate.

6 Mar 2014

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a key biomarker for inflammation. Studies show that MPO levels are useful predictors of near-term (one to six months) risk of heart attack or stroke.

6 Mar 2014

Elsevier launches medical reference and learning platforms for clinicians, students

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the fully redesigned Expert Consult and Student Consult, its two medical reference and learning platforms, now powered by Inkling, the creator of engaging, intuitive digital books for some of the world's most respected publishers.

6 Mar 2014

Alkermes initiates pivotal clinical development program for treatment of MDD

Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

6 Mar 2014

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.

6 Mar 2014

Scientists recommend psychological counselling to help patients remain active till donor heart is found

For many people with advanced cardiac insufficiency, a heart transplant may be their only hope. But waiting for a donor heart to come along is a race against time.

6 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Insect Cookbook promotes insects as meat for future in the western world

The presentation of The Insect Cookbook - Food for a Sustainable Planet on Monday 17 March is an important step to promote insects as the meat for the future in the Western world. The first copy will be presented to professor Louise O. Fresco, the future (as of July 1st) chairperson of the Board of Wageningen UR (University & Research centre)

6 Mar 2014

First Edition: March 6, 2014

Today's headlines include reports about health law rule changes announced yesterday by the Obama administration.

6 Mar 2014

Four MAXIMUS centers recognized as Certified Centers of Excellence

MAXIMUS, a leading provider of government services worldwide, announced today that four of its customer contact centers have been recognized as "Certified Centers of Excellence" by BenchmarkPortal.

6 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

Scientists throw light on genetic mutation that causes ARVC5 in Newfoundland

Scientists have thrown light on the genetic mutation that causes a particularly severe genetic disease (ARVC5) on the Canadian island Newfoundland in 2008.

6 Mar 2014

Interactive Health announces acquisition of Health Solutions

Interactive Health, the leading provider of outcomes-based wellness programs, announced today an expansion of its capabilities with the acquisition of Health Solutions, an award-winning provider of onsite comprehensive wellness services to organizations in the United States and around the world.

6 Mar 2014

Cincinnati joins with children's hospitals to affirm critical role patient families play in making hospital stays

As National Patient Safety Awareness Week kicks off (March 2 - 8, 2014) Cincinnati Children's Hospital Medical Center is joining forces with children's hospitals around the country to affirm the critical role patient families play in making hospital stays as safe as possible for their children.

6 Mar 2014

Reports warn about link between eating red and processed meat

Recent reports warn about a link between eating red and processed meat and the risk of developing cancer in the gut. These reports have resulted in new nutritional recommendations that advise people to limit their intake of red and processed meats.

6 Mar 2014

Scientists open door to development of new drugs to combat osteoporosis

Scientists from the University of Granada (UGR) have opened the door to the development of new drugs against osteoporosis, one of the most common chronic illnesses in the world, especially among women 65 or over.

6 Mar 2014

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg.

6 Mar 2014

Researchers identify high-speed cellular transport mechanism

Our DNA and its architecture are duplicated every time our cells divide. Histone proteins are key building blocks of this architecture and contain crucial information that regulates our genes. Danish researchers show how an enzyme controls reliable and high-speed delivery of histones to DNA copying hubs in our cells. This shuttling mechanism is crucial to maintain normal function of our genes and prevent disease. The results are published in the journal Nature Communications.

6 Mar 2014